Steve Wolk. Characterization of gRNAs and Ribonucleoproteins for CRISPR Applications. Presented at TIDES USA Oligonucleotide and Peptide Therapeutics, September 20-23, 2021.

Sep

25

Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer

Sep

25

Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer

Aug

30

Editas Medicine Announces Upcoming Investor Events